These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9016326)

  • 21. Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules.
    Dutta AK; Davis MC; Fei XS; Beardsley PM; Cook CD; Reith ME
    J Med Chem; 2002 Jan; 45(3):654-62. PubMed ID: 11806716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
    J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of meperidine analogues at monoamine transporters.
    Lomenzo SA; Rhoden JB; Izenwasser S; Wade D; Kopajtic T; Katz JL; Trudell ML
    J Med Chem; 2005 Mar; 48(5):1336-43. PubMed ID: 15743177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label.
    Dutta AK; Fei XS; Vaughan RA; Gaffaney JD; Wang N; Lever JR; Reith ME
    Life Sci; 2001 Mar; 68(16):1839-49. PubMed ID: 11292062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter.
    Newman AH; Izenwasser S; Robarge MJ; Kline RH
    J Med Chem; 1999 Sep; 42(18):3502-9. PubMed ID: 10479283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
    Chen N; Zhen J; Reith ME
    J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?
    Xu C; Reith ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1340-8. PubMed ID: 8819521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
    J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
    Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
    J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
    Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
    Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents.
    Lewis DB; Matecka D; Zhang Y; Hsin LW; Dersch CM; Stafford D; Glowa JR; Rothman RB; Rice KC
    J Med Chem; 1999 Dec; 42(24):5029-42. PubMed ID: 10585212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
    Zhang S; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
    Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
    Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
    Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
    J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, ligand binding, and quantitative structure-activity relationship study of 3 beta-(4'-substituted phenyl)-2 beta-heterocyclic tropanes: evidence for an electrostatic interaction at the 2 beta-position.
    Kotian P; Mascarella SW; Abraham P; Lewin AH; Boja JW; Kuhar MJ; Carroll FI
    J Med Chem; 1996 Jul; 39(14):2753-63. PubMed ID: 8709106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
    Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
    Volz TJ; Kim M; Schenk JO
    Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
    Holmquist CR; Keverline-Frantz KI; Abraham P; Boja JW; Kuhar MJ; Carroll FI
    J Med Chem; 1996 Oct; 39(21):4139-41. PubMed ID: 8863789
    [No Abstract]   [Full Text] [Related]  

  • 40. O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
    Madras BK; Reith ME; Meltzer PC; Dutta AK
    Eur J Pharmacol; 1994 Apr; 267(2):167-73. PubMed ID: 8050478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.